Concept and Strategy Development
Illuminate a path to consumer health success
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
Holding Steady – Global OTC Market Update Q2 MAT.
Sep 26, 2023
The first half of 2023 was a period of stability throughout the market as the world continued its recovery from the COVID pandemic, while wrestling with the more immediate challenges of inflation, pricing, and cost of living.
As we enter the final months of 2023, two key factors continue to dominate the global OTC market – the rebound of cough, cold and respiratory (CCR) product sales and the impact of inflation on pricing and the cost of living.
Driven by these factors, the global OTC market to MAT Q2 2023 posted growth of 8.5% to US$187 billion (see Exhibit 1) – including e-commerce and mass market estimates and excluding Venezuela – which while slower than the prior year period, it is still well ahead of the pre-COVID levels.
Exhibit 1 – Global OTC Market size and growth Q2 MAT 2023 (Source – IQVIA Global OTC Insights including estimates of e-commerce and mass-market, excluding Venezuela)
Inflation and pricing driving regional performance
As Exhibit 2 shows, Latin America and EMEA posted strong double-digit growth through the Q2 MAT period, with both regions’ performances driven by inflation pushing up prices and adding to the growth.
In EMEA, 3 of the top 5 markets that make up 50% of sales in the regions - Germany (14.5% share, +11.7% growth); Russia (11.8% share, +4.8% growth); Italy (10.9% share, +10.2% growth); France (10.3% share, +3.4% growth); Poland (6.0% share, +10.8% growth) – posted double digit growth.
Taking Poland as an example, price increases (following a double-digit CPI rate) contributed around 8% of the overall OTC market growth, bolstered further by new products/packs, while market volume fell over the same period.
By contrast in France – where growth was just 3.4% - while there had been some pricing impact in the [OTC33 segment], unit growth of 2.2% bolstered the OTC segment. Outside of OTC, the consumer health market performed much better, with the Food supplement segment performing with value sales up by 8.8% and volume up by 9.5%, driven primarily by the Sleep & Mood categories thanks to recent launches of P&G’s Zzquil and Richelet brands backed by significant promotional support.
While APAC also posted double digit OTC market growth, the region’s performance was down to robust growth in China – which posted sales up by 12.2% - which accounts for 40.3% of the total APAC market.
Exhibit 2 – Q2 MAT 2023 Global OTC market growth and share broken down by region (Source – IQVIA Global OTC Insights)
CCR’s long tail boosts company performance
Exhibit 3 – Q2 MAT 2023 Global OTC market growth and share broken down by category (Source – IQVIA Global OTC Insights)
The continued rapid growth in the cough, cold and respiratory category - +18.9% in Q2 MAT 2023 (see Exhibit 3) – was the key driver of growth for the best performing consumer health companies over the period.
Firms with CCR-weighted portfolios outperformed overall market growth, with P&G driven by Vicks, Reckitt driven by Mucinex and Stada driven by Grippostad leading the growth over the period.
Exhibit 4: Top 10 company performance and share Q2 MAT (Source: IQVIA Global OTC Insights)
Germany-based Stada was the standout performer, with the company’s overall Consumer Health sales growing by 12.6% thanks to increased demand for cough and cold products, expanded market share, price adjustments and positive effects from distribution collaborations (see Exhibit 4).
New product launches such as Elotrans Reload, Nizoral daily/anti-itch shampoo, Cetraben Pro Hydrate Five range, Hoggar Melatonin Duo and Sedatol Gold – coupled with a further marketing and distribution agreement with Sanofi in Eurasia for brands such as Buscopan, Enterogermina, Finalgon and Maalox, following a similar agreement in Northern Europe late last year – was behind the performance, which was the best out of the Top 10 biggest OTC companies.
On the opposite end of the scale, Bayer Consumer Health’s 1.9% growth – the slowest in the Top 10 – comes as the Germany pharmaceutical giant announced that it was launching a strategic review lead by new CEO Bill Anderson, putting the possibility of a Consumer Health spin off similar to those under taken by GSK (Haleon), Johnson & Johnson (Kenvue) and Sanofi (Opella) on the table.
For more information on the global OTC market or to request an SMR from our IQVIA Consumer Health experts click the contact us button on this page or visit our Global Consumer Health Trends 2023 webpage for an in-depth look at the state of the market today.
Contributors:
Dawid Zajkowski, Senior Consultant, Poland, IQVIA
Flore Coudy, Associate Marketing Director, France, IQVIA
Related solutions
Product and Claim Development
Compelling claims to capture the minds of consumers
Registration and Market Authorization
Navigate regulatory pathways with confidence
Launch Strategy and Planning
Unique launch strategies to make your products shine
Commercialization and Lifecycle Management
Adapt fast, maintain momentum and stay relevant
Global Consumer Health Trends 2023
Global Consumer Health Trends 2023 gives you expert-driven local insights on today's global challenges, so you can succeed in a dynamic, fast-changing consumer health market. Get the latest on 4 crucial market-impacting trends: consumer mindset, pricing, e-Pharmacy, and digital innovation.